(ASX:IPD)
ImpediMed’s (ASX: IPD) bioimpedance spectroscopy (BIS) devices accurately and noninvasively measure a patient’s total body water, and extracellular and intracellular fluid volumes to aid in the assessment and interventions for chronic diseases.